{'fraction_non_alphanumeric': 0.011178861788617886, 'fraction_numerical': 0.0, 'mean_word_length': 6.13768115942029, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Transurethral microwave thermotherapy: refining treatment strategy for benign prostatic hyperplasia

Transurethral microwave thermotherapy is a promising, minimally invasive treatment for patients with complaints related to benign prostatic hyperplasia. Since the initial review of transurethral microwave thermotherapy for benign prostatic hyperplasia in Current Opinion in Urology, data continue to mature. The results of phase II studies and placebo control studies suggest real therapeutic benefit for certain patient groups who undergo this treatment. A number of reports have appeared that confirm the thermotherapy principle, and add to the knowledge of patient selection and provide data to suggest that the treatment is durable. Consistently, transurethral microwave thermotherapy appears to be a remarkably safe procedure, and refinement in patient selection will confirm a place for this treatment between medical and surgical alternatives for benign prostatic hyperplasia.